Skip to main content
. 2020 May 30;21(11):3906. doi: 10.3390/ijms21113906

Table 1.

FDA approved CAR-T therapies.

Therapy Trade Name Approved for Patient Population Approval Date
Tisagenlecleucel Kymriah Large B-cell lymphomas Adult 1 May 2018
B-cell precursor acute lymphoblastic leukemia Up to 25 years of age 30 August 2017
Axicabtagene ciloleucel Yescarta Large B-cell lymphomas Adult 18 October 2017